Annabel Blasi
Grup de recerca
- Esteatohepatitis i trasplantament de fetge Accredited researcher (R3A)
Publicacions destacades
-
Coagulation failure in patients with Acute-on-Chronic Liver Failure (ACLF) and decompensated cirrhosis: beyond INR.
Autors:Referència: Hepatology 2018. -
Time to change the classical vision of coagulation in liver disease: from the balance disequilibrium to the systems biology network modelling.
Autors:Referència: Minerva Anestesiologica 2018. -
Assessment of rotational thromboelastometry for the prediction of red blood cell requirements in orthotopic liver transplantation.
Autors:Referència: Minerva Anestesiologica 2018. -
Venous Thrombotic Events After Liver Transplantation.
Autors:Referència: Clinical And Applied Thrombosis-Hemostasis 2018. -
Correlation between plasma fibrinogen and FIBTEM thromboelastometry during liver transplantation: a comprehensive assessment
Autors:Referència: Vox Sanguinis 2017. -
Transfusion Prediction Model in Orthotopic Liver Transplantation Based on Thromboelastometry: Prospective Validation Study
Autors:Referència: Transplantation 2017. -
Increased risk of portal vein thrombosis in patients with autoimmune hepatitis on the liver transplantation waiting list.
Autors:Referència: Clinical Transplantation 2017. -
Impact of pre-emptive fibrinogen concentrate on transfusion requirements in liver transplantation: a multicenter, randomized, double-blind, placebo-controlled trial
Autors:Referència: American Journal Of Transplantation 2016. -
Liver Transplant From Unexpected Donation After Circulatory Determination of Death Donors: A Challenge in Perioperative Management
Autors:Referència: American Journal Of Transplantation 2016.
Projectes destacats
-
Impacto de dos estrategias transfusionales guiadas por tromboelastograma sobre el consumo de concentrados de hematíes en el trasplante hepático: estudio multicentrico y aleatorizado
Investigador/a principal: Annabel Blasi IbanezFinançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Instituto de Salud Carlos III (FIS); Instituto de Salud Carlos IIIDurada: 01/01/2018 - 31/12/2020 -
Liver cirrhosis study. Tem Innovation GmbH
Investigador/a principal: Annabel Blasi IbanezDurada: 01/01/2018 -
Ensayo clínico, multicéntrico, aleatorio y controlado con placebo para evaluar la eficacia de la administración de concentrado de fibrinógeno sobre los requerimientos de derivados sanguíneos en la cirugía del trasplante hepático
Finançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Ministerio de Sanidad Política Social e IgualdadDurada: 01/01/2010 - 01/01/2013 -
Glucemia en el transplante hepatico: factores pronóstico y impacto sobre el funcionalismo del injerto
Finançador: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Ministerio de Sanidad y ConsumoDurada: 01/01/2010 - 01/01/2013